Results 31 to 40 of about 207,197 (306)

Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future [PDF]

open access: yes, 2014
Serological techniques commonly used to quantify influenza-specific antibodies include the Haemagglutination Inhibition (HI), Single Radial Haemolysis (SRH) and Virus Neutralization (VN) assays.
Callow   +30 more
core   +3 more sources

Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: A case-based review [PDF]

open access: yes, 2020
Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatological condition affecting individuals aged >50 years. There have been rare reports of PMR and other vasculitides developing within 3 months of influenza vaccination.
Bassendine, Margaret F., Bridge, Simon
core   +1 more source

Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective

open access: yesVaccines, 2018
Vaccination against influenza is the most effective approach for reducing influenza morbidity and mortality. However, influenza vaccines are unique among all licensed vaccines as they are updated and administered annually to antigenically match the ...
Surender Khurana
doaj   +1 more source

Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity

open access: yesVaccines, 2021
Influenza poses a huge threat to global public health. Influenza vaccines are the most effective and cost-effective means to control influenza. Current influenza vaccines mainly induce neutralizing antibodies against highly variable globular head of ...
Zhuofan Li   +3 more
doaj   +1 more source

Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age [PDF]

open access: yes, 2014
Background: Vaccines against pandemic A/H1N1 influenza should provide protective immunity in children, because they are at greater risk of disease than adults.
Abarca, Katia   +9 more
core   +2 more sources

Cell culture-derived flu vaccine: Present and future

open access: yesHuman Vaccines & Immunotherapeutics, 2018
The benefit of influenza vaccines is difficult to estimate due to the complexity of accurately assessing the burden of influenza. To improve the efficacy of influenza vaccines, vaccine manufacturers have developed quadrivalent influenza vaccine (QIV ...
Alberto Pérez Rubio, Jose María Eiros
doaj   +1 more source

Projected impact of a plant-derived vaccine on the burden of seasonal influenza in Canada

open access: yesHuman Vaccines & Immunotherapeutics, 2021
Objective The analysis estimates projected population outcomes resulting from the introduction of a plant-derived influenza vaccine formulated as quadrivalent virus-like particles (QVLP) in Canada.
Lauren Ramjee   +7 more
doaj   +1 more source

Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin [PDF]

open access: yes, 2012
BACKGROUND: Pigs have been implicated as mixing reservoir for the generation of new pandemic influenza strains, control of swine influenza has both veterinary and public health significance.
Bin Wang   +5 more
core   +1 more source

"VACCINES IN INFLUENZA" [PDF]

open access: yesJAMA: The Journal of the American Medical Association, 1918
To the Editor: —The current comment in your issue of October 19 prompts me to call attention to the efforts of this laboratory and base hospital to do something specific for influenza. It was obvious from the first that the virus was an overwhelming one, and it was noteworthy that uncomplicated influenza was associated with leukopenia and that the ...
openaire   +2 more sources

Virus-Vectored Influenza Virus Vaccines

open access: yesViruses, 2014
Despite the availability of an inactivated vaccine that has been licensed for >50 years, the influenza virus continues to cause morbidity and mortality worldwide.
Ralph A. Tripp, S. Mark Tompkins
doaj   +1 more source

Home - About - Disclaimer - Privacy